Cleanov (RO) Cancer Clinical Trials

A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

~39 mi. (Craiova, Romania, +356 more cities)

Onco Clinic Consult SA, +1 more facility

HER2 Positive

Invasive Breast Carcinoma

fam-trastuzumab deruxtecan

targeted therapy

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

~39 mi. (Craiova, Romania, +137 more cities)

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1101)

Skin Squamous Cell Carcinoma

pembrolizumab

immunotherapy

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

~39 mi. (Craiova, Romania, +126 more cities)

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 0394)

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

FOLFOX regimen, +3 more drugs

chemotherapy, +2 more types

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

~39 mi. (Craiova, Romania, +92 more cities)

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 0248)

Bladder Urothelial Carcinoma

chemotherapy, +2 more drugs

chemotherapy, +2 more types

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

~39 mi. (Craiova, Romania, +184 more cities)

Centrul de Oncologie "Sfântul Nectarie"

RET Fusion

Non-Squamous Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)

~39 mi. (Craiova, Romania, +105 more cities)

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1103)

ATM Loss, +62 more biomarkers

Breast Carcinoma, +2 more conditions

olaparib

targeted therapy

Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

~39 mi. (Craiova, Romania, +115 more cities)

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1103)

ATM Loss, +27 more biomarkers

Breast Carcinoma, +2 more conditions

olaparib, +1 more drug

immunotherapy, +1 more type

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

~39 mi. (Craiova, Romania, +228 more cities)

S.C. Centrul de Oncologie Sf. Nectarie S.R.L. /ID# 227623

MET Expression

Non-Small Cell Lung Carcinoma

telisotuzumab vedotin

chemotherapy, +1 more type